KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Total Debt (2020 - 2025)

Historic Total Debt for Oscar Health (OSCR) over the last 5 years, with Q4 2025 value amounting to $430.1 million.

  • Oscar Health's Total Debt rose 4357.8% to $430.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $430.1 million, marking a year-over-year increase of 4357.8%. This contributed to the annual value of $430.1 million for FY2025, which is 4357.8% up from last year.
  • As of Q4 2025, Oscar Health's Total Debt stood at $430.1 million, which was up 4357.8% from $686.3 million recorded in Q3 2025.
  • Oscar Health's 5-year Total Debt high stood at $686.3 million for Q3 2025, and its period low was $297.4 million during Q1 2022.
  • Over the past 4 years, Oscar Health's median Total Debt value was $298.9 million (recorded in 2023), while the average stood at $331.1 million.
  • The largest annual percentage gain for Oscar Health's Total Debt in the last 5 years was 12925.3% (2025), contrasted with its biggest fall of 25.99% (2025).
  • Over the past 4 years, Oscar Health's Total Debt (Quarter) stood at $298.0 million in 2022, then rose by 0.26% to $298.8 million in 2023, then increased by 0.26% to $299.6 million in 2024, then surged by 43.58% to $430.1 million in 2025.
  • Its last three reported values are $430.1 million in Q4 2025, $686.3 million for Q3 2025, and $299.9 million during Q2 2025.